Evaluating Therapeutic Efficacy against Cancer Stem Cells: New Challenges Posed by a New Paradigm
Open Access
- 1 November 2007
- journal article
- editorial
- Published by Elsevier in Cell Stem Cell
- Vol. 1 (5) , 497-501
- https://doi.org/10.1016/j.stem.2007.10.005
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Chemical genetics reveals a complex functional ground state of neural stem cellsNature Chemical Biology, 2007
- Economics of New Oncology Drug DevelopmentJournal of Clinical Oncology, 2007
- A Perivascular Niche for Brain Tumor Stem CellsCancer Cell, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Cancer nanotechnology: opportunities and challengesNature Reviews Cancer, 2005
- Magnitude of Response With Myeloma Frontline Therapy Does Not Predict Outcome: Importance of Time to Progression in Southwest Oncology Group Chemotherapy TrialsJournal of Clinical Oncology, 2004
- Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trialThe Lancet, 2003
- Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML)Blood, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997